Skip to main content
Fig. 1 | Trials

Fig. 1

From: The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials

Fig. 1

SYGMA1 study design. bid twice daily, E enrolment, EM electronic monitoring twice daily (eDiary), FU follow-up phone call, TUM Turbuhaler® Usage Monitor, recording use of each blinded study inhalers. †Corresponds to the terbutaline Turbuhaler® 0.4 mg, with regards to the dose delivered

Back to article page

Trials

ISSN: 1745-6215